P1563: REMDESIVIR USE IN SEVERE AND CRITICAL COVID-19 PATIENTS MIGHT BE ASSOCIATED WITH LOWER INCIDENCE OF ARTERIAL THROMBOTIC EVENTS

P1563: REMDESIVIR USE IN SEVERE AND CRITICAL COVID-19 PATIENTS MIGHT BE ASSOCIATED WITH LOWER INCIDENCE OF ARTERIAL THROMBOTIC EVENTS

Podrobná bibliografie
Hlavní autoři: Marko Lucijanic, Petra Bistrovic, Ana Jordan, Iva Mihaljevic, Stela Bukvic, Stjepan Kovacevic, Darjan Ranilovic, Sara Sakota, Josipa Vlasac Glasnovic, Diana Delic-Brkljacic
Médium: Článek
Jazyk:English
Vydáno: Wiley 2023-08-01
Edice:HemaSphere
On-line přístup:http://journals.lww.com/10.1097/01.HS9.0000973128.79769.f1

Internet

http://journals.lww.com/10.1097/01.HS9.0000973128.79769.f1

Podobné jednotky